NUMIF - Psychedelics-Focused Numinus Plans To Leverage This AI Technology Via New Strategic Acquisition | Benzinga
Psychedelics-focused mental healthcare company Numinus Wellness Inc. (TSX:NUMI) (OTCQX:NUMIF) (FSE: LR23) plans to take over MedBright AI Investments Inc. (CSE:MBA).
The proposed transaction comes as the Vancouver-based company reorganizes its operations with a near-term strategic plan toward generating positive EBITDA.
What Happened
Numinus announced the execution of a letter of intent Thursday to acquire MedBright which deploys artificial intelligence and machine learning to allow medical professionals to deliver increased access to healthcare, reduce healthcare costs and improve patient outcomes, by way of a statutory plan of arrangement.
Under the deal, Numinus plans to issue 1.86 of its common shares for each MedBright AI share. It is anticipated that Numinus will issue an ...